Status:
COMPLETED
Belgian Screening Project for the Detection of Anderson-Fabry Disease in Hypertrophic Cardiomyopathy
Lead Sponsor:
University Hospital, Ghent
Conditions:
Left Ventricular Hypertrophy
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to determine the prevalence of Fabry mutations in patients with left ventricular hypertrophy (moderate to severe), as measured by echocardiography.This study is a screenin...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- All patients over 18 years undergoing a routine echocardiography in the participating hospitals
- Both genders will be considered.
- Patients can be included if on 2D echocardiography the maximal septal wall thickness \> 13 mm and/or the posterior wall thickness \> 13 mm. The limit for inclusion is kept relatively low to detect early forms of Fabry cardiomyopathy.
Exclusion
Key Trial Info
Start Date :
July 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2011
Estimated Enrollment :
540 Patients enrolled
Trial Details
Trial ID
NCT01198899
Start Date
July 1 2009
End Date
August 1 2011
Last Update
January 12 2012
Active Locations (9)
Enter a location and click search to find clinical trials sorted by distance.
1
AZ Imelda
Bonheiden, Belgium
2
AZ Sint-Blasius
Dendermonde, Belgium
3
AZ Sint-Lucas
Ghent, Belgium
4
Maria Middelares
Ghent, Belgium